CCND1 and malignant colon neoplasm: Initial key studies carried out by Tetsu et al. and Shtutman et al. in colon cancers revealed that β-catenin activates transcription from the cyclin D1 (CCND1) promoter, and consensus TCF/LEF-binding sites are necessary for this activity 42, 43.